MAML3 and neoplasm: From a clinical standpoint, this Wnt expressional cluster also contains PPGLs at risk of metastatic dissemination, probably arguing for tumor DNA screening of MAML3 gene fusions and CDSE1 mutations as an efficient way to identify additional high-risk cases that will be negative for other TCA cycle and pseudo-hypoxia-related aberrancies [5, 29].